Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,873 | 209 | 58.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,729 | 1 | 41.2% |
| Education | $27.78 | 2 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $3,314 | 23 | $0 (2018) |
| GlaxoSmithKline, LLC. | $878.94 | 70 | $0 (2023) |
| Philips Electronics North America Corporation | $451.34 | 1 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $272.17 | 15 | $0 (2018) |
| Genentech USA, Inc. | $247.89 | 16 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $202.93 | 10 | $0 (2018) |
| Respiratory Technologies, Inc. | $120.18 | 8 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $108.21 | 7 | $0 (2018) |
| Sunovion Pharmaceuticals Inc. | $106.38 | 7 | $0 (2018) |
| Shire North American Group Inc | $90.58 | 4 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $15.20 | 1 | GlaxoSmithKline, LLC. ($15.20) |
| 2018 | $1,427 | 68 | Philips Electronics North America Corporation ($451.34) |
| 2017 | $5,188 | 143 | Boehringer Ingelheim Pharmaceuticals, Inc. ($3,221) |
All Payment Transactions
212 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/01/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: RESPIRATORY | ||||||
| 08/02/2018 | Advanced Respiratory, Inc | The Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Airway Clearance Device | ||||||
| 08/01/2018 | Genentech USA, Inc. | Xolair (Biological), Esbriet | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Immunology | ||||||
| 08/01/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug) | Education | In-kind items and services | $13.89 | General |
| Category: RESPIRATORY | ||||||
| 07/09/2018 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: Cardiology | ||||||
| 06/27/2018 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: RESPIRATORY | ||||||
| 06/25/2018 | Sunovion Pharmaceuticals Inc. | Utibron (Drug), Seebri, Lonhala Magnair | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Respiratory | ||||||
| 06/21/2018 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: RESPIRATORY | ||||||
| 06/20/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: RESPIRATORY | ||||||
| 06/19/2018 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: GIAPREZA | ||||||
| 06/14/2018 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Immunology | ||||||
| 06/11/2018 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $1.62 | General |
| Category: RESPIRATORY | ||||||
| 06/09/2018 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $12.48 | General |
| Category: RESPIRATORY | ||||||
| 06/01/2018 | Circassia Pharmaceuticals Inc | TUDORZA PRESSAIR (Drug), NIOX VERO | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: PULMONARYRESPIRATORY DISEASES | ||||||
| 05/30/2018 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: RESPIRATORY | ||||||
| 05/18/2018 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Respiratory | ||||||
| 05/16/2018 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: RESPIRATORY | ||||||
| 05/16/2018 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $0.96 | General |
| Category: RESPIRATORY | ||||||
| 05/14/2018 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: RESPIRATORY | ||||||
| 05/11/2018 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: RESPIRATORY | ||||||
| 05/10/2018 | Genentech USA, Inc. | Esbriet (Biological) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Immunology | ||||||
| 05/09/2018 | Sunovion Pharmaceuticals Inc. | Utibron (Drug), Seebri, Lonhala Magnair | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Respiratory | ||||||
| 05/08/2018 | Jazz Pharmaceuticals Inc. | Xyrem (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: Neurology | ||||||
| 05/03/2018 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Immunology | ||||||
| 05/02/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), BREO, INCRUSE | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 40 | 58 | $12,834 | $4,342 |
| 2022 | 3 | 65 | 88 | $20,865 | $8,081 |
| 2021 | 4 | 99 | 145 | $28,775 | $11,478 |
| 2020 | 5 | 168 | 231 | $43,516 | $14,215 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 28 | 46 | $10,902 | $3,841 | 35.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 12 | $1,932 | $501.02 | 25.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 32 | 41 | $9,717 | $4,109 | 42.3% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 14 | 21 | $5,936 | $2,185 | 36.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 19 | 26 | $5,212 | $1,788 | 34.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 32 | 48 | $11,376 | $4,697 | 41.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 27 | 44 | $7,084 | $2,718 | 38.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 15 | 22 | $5,324 | $2,217 | 41.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 25 | 31 | $4,991 | $1,846 | 37.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 47 | 77 | $12,397 | $4,954 | 40.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 31 | 44 | $10,648 | $4,143 | 38.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 42 | 55 | $13,035 | $3,725 | 28.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 37 | 44 | $7,084 | $1,292 | 18.2% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Facility | 2020 | 11 | 11 | $352.00 | $101.08 | 28.7% |
About Dr. Richard Zuwallack, MD
Dr. Richard Zuwallack, MD is a Pulmonary Disease healthcare provider based in Hartford, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1033111455.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Zuwallack, MD has received a total of $6,630 in payments from pharmaceutical and medical device companies, with $15.20 received in 2023. These payments were reported across 212 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($3,873).
As a Medicare-enrolled provider, Zuwallack has provided services to 372 Medicare beneficiaries, totaling 522 services with total Medicare billing of $38,116. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty Pulmonary Disease
- Location Hartford, CT
- Active Since 08/15/2005
- Last Updated 06/23/2021
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1033111455
Products in Payments
- SPIRIVA (Drug) $2,729
- Wellcentive Undiv (Device) $451.34
- ELIQUIS (Drug) $227.78
- BREO (Drug) $189.02
- ANORO (Drug) $151.12
- Esbriet (Biological) $148.45
- TRELEGY ELLIPTA (Drug) $142.51
- OFEV (Drug) $140.59
- STIOLTO (Drug) $136.39
- SYMBICORT (Drug) $126.33
- PRADAXA (Drug) $125.00
- NUCALA (Biological) $105.06
- Xolair (Biological) $99.44
- GLASSIA (Biological) $90.58
- Prolastin-C (Biological) $81.31
- ASMANEX (Drug) $81.21
- The Vest System Model 105 Home Care (Device) $76.85
- BEVESPI AEROSPHERE (Drug) $76.38
- Adempas (Drug) $63.15
- SOLIRIS (Drug) $51.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Hartford
Daniel Gerardi, Md, MD
Pulmonary Disease — Payments: $131,554
James Pope, Md, MD
Pulmonary Disease — Payments: $59,197
Eric Shore, Md, MD
Pulmonary Disease — Payments: $38,225
John Russomanno, Md, MD
Pulmonary Disease — Payments: $16,927
Phyllis Schatz, Md, MD
Pulmonary Disease — Payments: $5,543
Prashant Grover, M.d, M.D
Pulmonary Disease — Payments: $4,099